Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2013

Open Access 01-11-2013 | Meeting abstract

PW01-028 – Developing a new severity score for FMF

Authors: E Demirkaya, C Acikel, A Gul, M Gattorno, E Ben-Chetrit, H Ozdogan, P Hashkes, A Polat, O Karadag, A Livneh, S Ozen, FMF Arthritis Vasculitis and Orphan disease Research in Pediatric Rheumatology (FAVOR)

Published in: Pediatric Rheumatology | Special Issue 1/2013

Login to get access

Excerpt

Severity is a basic feature that defines the prognosis of a disease. FMF presents with a variety of clinic and laboratory manifestations affecting severity, and evaluation of prognosis is an elusive task. Different severity scores have been previously proposed for FMF, and commonly used ones include Mor, Pras and Tel Hashomer severity scores however recent studies showed that there is no consistency among them. …
Metadata
Title
PW01-028 – Developing a new severity score for FMF
Authors
E Demirkaya
C Acikel
A Gul
M Gattorno
E Ben-Chetrit
H Ozdogan
P Hashkes
A Polat
O Karadag
A Livneh
S Ozen
FMF Arthritis Vasculitis and Orphan disease Research in Pediatric Rheumatology (FAVOR)
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A81

Other articles of this Special Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue

Meeting abstract

P01-019 – Anti-CCP antibodies are not associated with FMF

Meeting abstract

PW02-038 - Treatment-resistant NOMID with autoantibodies

Meeting abstract

PW01-022 – Dissociation between CRP and SAA in FMF

Meeting abstract

PW01-015 – Canakinumab in adults with colchicin resistant FMF

Meeting abstract

OR10-006 - Canakinumab in patients with TRAPS

Meeting abstract

P02-024 - Clinical impact of V198M mutation in NLRP3 gene